Monogenic lupus - from gene to targeted therapy.

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disorder involving loss of self-tolerance to nuclear antigens.
• Autoantibodies and immune complex deposition cause widespread inflammatory tissue damage.
• Current treatments for SLE involve immunosuppressants with significant side effects, and no cure exists.

Purpose of the Study:

• To investigate the molecular mechanisms of systemic autoimmunity through rare monogenic forms of SLE.
• To leverage insights from monogenic SLE for developing improved diagnostic and therapeutic strategies.
• To guide the development of targeted therapies for both monogenic and complex SLE.

Main Methods:

• Analysis of rare monogenic forms of SLE.
• Elucidation of molecular pathways in systemic autoimmunity.
• Biomarker profiling for diagnosis and monitoring.

Main Results:

• Identification of key molecular mechanisms underlying systemic autoimmunity.
• Insights into the genetic basis of SLE.
• Foundation for developing novel therapeutic targets.

Conclusions:

• Understanding monogenic SLE is crucial for advancing treatment for all forms of the disease.
• Targeted therapies and refined biomarker profiles are potential outcomes.
• This research paves the way for more effective SLE management.